These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17452126)

  • 1. Advances in sepsis research derived from animal models.
    Männel DN
    Int J Med Microbiol; 2007 Sep; 297(5):393-400. PubMed ID: 17452126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory caspases: guardians against infections and sepsis.
    Scott AM; Saleh M
    Cell Death Differ; 2007 Jan; 14(1):23-31. PubMed ID: 16977333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death during sepsis: integration of disintegration in the inflammatory response to overwhelming infection.
    Pinheiro da Silva F; Nizet V
    Apoptosis; 2009 Apr; 14(4):509-21. PubMed ID: 19199035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils as potential therapeutic targets in sepsis.
    Brown KA; Treacher DF
    Discov Med; 2006 Jun; 6(33):118-22. PubMed ID: 17234146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunomorphologic aspects of sepsis in children under 1-year-old].
    Gurevich PS; Barsukov VS
    Arkh Patol; 1982; 44(3):74-9. PubMed ID: 7082193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental models of sepsis and their clinical relevance.
    Poli-de-Figueiredo LF; Garrido AG; Nakagawa N; Sannomiya P
    Shock; 2008 Oct; 30 Suppl 1():53-9. PubMed ID: 18704008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory anti-inflammatory response syndrome.
    Adib-Conquy M; Cavaillon JM
    Thromb Haemost; 2009 Jan; 101(1):36-47. PubMed ID: 19132187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide: an endotoxin or an exogenous hormone?
    Marshall JC
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S470-80. PubMed ID: 16237650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunopathology of sepsis and potential therapeutic targets.
    van der Poll T; van de Veerdonk FL; Scicluna BP; Netea MG
    Nat Rev Immunol; 2017 Jul; 17(7):407-420. PubMed ID: 28436424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immune system in critical illness.
    Marshall JC; Charbonney E; Gonzalez PD
    Clin Chest Med; 2008 Dec; 29(4):605-16, vii. PubMed ID: 18954696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of inflammation and sepsis: a primer.
    Cinel I; Opal SM
    Crit Care Med; 2009 Jan; 37(1):291-304. PubMed ID: 19050640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response to severe bacterial infections: consequences for therapy.
    Giamarellos-Bourboulis EJ; Raftogiannis M
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):369-80. PubMed ID: 22397569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When intracellular pathogens invade the frontiers of cell biology and immunology.
    Pizarro-Cerdá J; Moreno E; Desjardins M; Gorvel JP
    Histol Histopathol; 1997 Oct; 12(4):1027-38. PubMed ID: 9302565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders.
    Meyer U; Feldon J; Fatemi SH
    Neurosci Biobehav Rev; 2009 Jul; 33(7):1061-79. PubMed ID: 19442688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate recognition of bacteria: potential therapeutic targets for bacterial sepsis.
    Triantafilou K; Triantafilou M
    Expert Rev Clin Immunol; 2006 Sep; 2(5):787-99. PubMed ID: 20477633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter-based mouse models of digestive system carcinogenesis.
    Rogers AB; Houghton J
    Methods Mol Biol; 2009; 511():267-95. PubMed ID: 19347301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis: time has come to focus on the later stages.
    Schefold JC; Hasper D; Volk HD; Reinke P
    Med Hypotheses; 2008 Aug; 71(2):203-8. PubMed ID: 18448264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexities of targeting innate immunity to treat infection.
    Brown KL; Cosseau C; Gardy JL; Hancock RE
    Trends Immunol; 2007 Jun; 28(6):260-6. PubMed ID: 17468048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune monitoring in SIRS and sepsis based on the PIRO model].
    Meisel C; Höflich C; Volk HD
    Dtsch Med Wochenschr; 2008 Nov; 133(45):2332-6. PubMed ID: 18958829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.